US.HUM · Humana

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 0.9,
      "details": {
        "atrPct": 5.075598268233503,
        "turnoverUsdM": 794.59260726,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.3
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.HUM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 377.7064,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 1,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.7,
      "stop_loss_percent": 10.2,
      "take_profit_price": 492.3561,
      "target_multiplier": 2.2,
      "technical_strength": 2.3,
      "take_profit_percent": 17.1
    },
    "positionPoints": 0.9,
    "stopLossPoints": 0.6,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.6845304825465863,
    "stopLossPercent": 10.151196536467006,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 75.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 58.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 17
  },
  "market": {
    "ma20": 393.145,
    "ma50": 390.328,
    "close": 420.38,
    "prevClose": 433.5,
    "avgVolume20": 1596594,
    "volumeRatio": 1.18,
    "changePercent": -3.03
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 17,
    "details": {
      "ret_5d": 0.03984963118335849,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 17,
      "vcp_bonus": 0,
      "vol_ratio": 1.223668979982909,
      "ret_points": 8,
      "vol_points": 4,
      "range_ratio": 2.1118408665906796,
      "volat_points": 4,
      "day_range_pct": 0.07703746610209816,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 75.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 56,
        "contribution": 2.8
      },
      {
        "raw": 11.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 58,
        "contribution": 11.6
      },
      {
        "raw": 8.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 54.67,
        "contribution": 8.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.3,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 53,
        "contribution": 5.3
      },
      {
        "raw": 22.2,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 74,
        "contribution": 22.2
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 58.1,
    "details": [
      "基本面分析總分: 2.8/5分",
      "資金流分析總分: 11.6/20分",
      "市場環境分析總分: 8.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.3/10分",
      "技術信號分析總分: 22.2/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.8,
      "資金流": 11.6,
      "市場環境": 8.2,
      "情緒分析": 6,
      "技術信號": 22.2,
      "風險管理": 5.3
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 794.59260726,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 3.2,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.HUM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.21
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 741.33600115,
                "ma50": 726.5544004600001,
                "name": "QQQ",
                "close": 743.57001,
                "points": 2
              },
              "spy": {
                "ma20": 769.8689970499998,
                "ma50": 768.6025973799999,
                "name": "SPY",
                "close": 778.01001,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 5.075598268233503,
          "atrPoints": 1,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142853565,
                "url": "https://finnhub.io/api/news?id=8860291f50f2b604f4723fe07dcfefd309331d5672f5a155cef32c244dd3a261",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) has created a new joint venture with BlackRock's HPS Investment Partners to grow CenterWell Senior Primary Care clinics. The partnership includes HPS acquiring Welsh, Carson, Anderson & Stowe's equity interest in CenterWell's senior primary care platform. BlackRock's HPS unit becomes the majority owner in the venture, which is structured to supply capital for clinic expansion and operations. The joint venture with BlackRock's HPS to fund CenterWell clinics is only one piece...",
                "category": "company",
                "datetime": 1791915413,
                "headline": "Humana (HUM) Forms New Joint Venture To Fund CenterWell Clinic Growth"
              },
              {
                "id": 142823813,
                "url": "https://finnhub.io/api/news?id=a43a22a16072cca6c4d59306f0111e72c743c74abf96ea1b7bf78760e3178f70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "On October 9, Humana Inc. (NYSE:HUM) gained more than 11% after analysts named it the biggest potential beneficiary of the new Medicare Advantage star ratings for 2027. Earlier this year, the stock also ranked 5th on our list of the 7 Best Turnaround Stocks to Buy in 2026. See which four stocks ranked higher than […]",
                "category": "company",
                "datetime": 1791830349,
                "headline": "Humana (HUM) Gets a Major Ratings Boost. Can Earnings Justify the Valuation?"
              },
              {
                "id": 142823814,
                "url": "https://finnhub.io/api/news?id=c38a1fd70c073e2aa7ff4cca514382b82259cdbb678f2719e82c423d41ad1616",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.",
                "category": "company",
                "datetime": 1791825120,
                "headline": "Strength Seen in Humana (HUM): Can Its 11.6% Jump Turn into More Strength?"
              },
              {
                "id": 142821660,
                "url": "https://finnhub.io/api/news?id=211af12e3732a278657f2c71d03dd93048a232b99b048293b2fb0bf1d6c6b903",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana's 2027 Medicare Advantage ratings rebound puts 95% of members in four-star or better plans, potentially boosting 2028 bonus payments and plan benefits.",
                "category": "company",
                "datetime": 1791814860,
                "headline": "Humana Hits 95% Four-Star Coverage: What it Means for HUM"
              },
              {
                "id": 142811129,
                "url": "https://finnhub.io/api/news?id=aa4e6af2649f3f9eeb6605ff7b67664cda878a49a5317f2d94fbdf632020f8e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The rallies highlighted growth opportunities across biotechnology, health insurance and optical technology.",
                "category": "company",
                "datetime": 1791774188,
                "headline": "Why Did MRNA, HUM, LITE Stocks Surge To 52-Week Highs Last Week?"
              },
              {
                "id": 142773399,
                "url": "https://finnhub.io/api/news?id=baacacd7f6627bbc95e2292de15e100e01688f41649edba643a5ca47e1b12cc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "In early October 2026, BlueWind Medical announced that Humana began covering implantable tibial neuromodulation therapy for urgency urinary incontinence, including BlueWind’s Revi System, across its Medicare Advantage membership of about 11 million enrollees. This coverage decision, backed by multi‑year OASIS clinical data and a new AMA Category I CPT code for subfascial tibial neuromodulation, highlights how Humana may be broadening access to advanced, home‑managed therapies for seniors...",
                "category": "company",
                "datetime": 1791591288,
                "headline": "Humana (HUM) Deepens MA Neuromodulation Coverage: A Clue to Its Margin Recovery Strategy?"
              },
              {
                "id": 142768092,
                "url": "https://finnhub.io/api/news?id=1cab6596c18b84afa417c87209d7f9bd1c6eb2fb19b06bb0b97418f5368caea9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Shares of health insurance company Humana (NYSE:HUM) jumped 16.8% in the pre-market session after Robert W. Baird upgraded the company to Outperform from Neutral and raised its price target to $596 from $390, following an operational recovery in federal quality ratings.",
                "category": "company",
                "datetime": 1791584350,
                "headline": "Humana (HUM) Stock Trades Up, Here Is Why"
              },
              {
                "id": 142764310,
                "url": "https://finnhub.io/api/news?id=4d437e08fe466ed541bd5eef3750781e68f087ceaed459ad89e1ceddd5089ffb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s assessed fair value has shifted from US$419.04 to US$430.70 per share, giving investors an updated price anchor to compare with current trading levels. This adjustment aligns with recently more active research coverage, as analysts recalibrate targets while they reassess Medicare Advantage margins, cost trends and the potential impact of upcoming star ratings cycles. Read on to see how these evolving views on Humana could shape expectations and how you can keep track of the changing...",
                "category": "company",
                "datetime": 1791555246,
                "headline": "Humana (HUM) Stock Fair Value Edges Higher After Analyst Target Revisions"
              }
            ],
            "raw_source": [
              {
                "id": 142853565,
                "url": "https://finnhub.io/api/news?id=8860291f50f2b604f4723fe07dcfefd309331d5672f5a155cef32c244dd3a261",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) has created a new joint venture with BlackRock's HPS Investment Partners to grow CenterWell Senior Primary Care clinics. The partnership includes HPS acquiring Welsh, Carson, Anderson & Stowe's equity interest in CenterWell's senior primary care platform. BlackRock's HPS unit becomes the majority owner in the venture, which is structured to supply capital for clinic expansion and operations. The joint venture with BlackRock's HPS to fund CenterWell clinics is only one piece...",
                "category": "company",
                "datetime": 1791915413,
                "headline": "Humana (HUM) Forms New Joint Venture To Fund CenterWell Clinic Growth"
              },
              {
                "id": 142852637,
                "url": "https://finnhub.io/api/news?id=d5faf179fab3c6ef82c79eab72579477a150ee43092e627af4b02cfa88607bb6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx Commercialization with Hospital Systems, HMOs, GPOs and Cancer Centers TAMPA, FL – DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMeds AI,” “DataMEDS SI,” “DataMEDS,” or the “Company”), a healthcare company leveraging its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx and smart contracts platform PharmacyChain, today announced that it has implem",
                "category": "company",
                "datetime": 1791907861,
                "headline": "DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division"
              },
              {
                "id": 142852550,
                "url": "https://finnhub.io/api/news?id=b3ed7ed97081b39ca41dab17a48d1929eb3dfaf045001b56485978831fdb3c81",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investment firm BlackRock will acquire a majority stake in nearly 150 senior primary care clinics owned by Humana’s healthcare division, CenterWell, the insurer announced Tuesday.",
                "category": "company",
                "datetime": 1791907747,
                "headline": "Humana enters $2.8B primary care joint venture with BlackRock"
              },
              {
                "id": 142850488,
                "url": "https://finnhub.io/api/news?id=251766da1e5b52b9f8d9aa0b816bae4f1afe5880c09586fb51895499921bf780",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Curious about the S&P500 stocks that are gapping on Tuesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1791902101,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 142848748,
                "url": "https://finnhub.io/api/news?id=e7c246f75de1b3572408a1533717337fd43ffc9169e22e353dca9e64156525dd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The 8:30 Hosts Julie Hyman, Pras Subramanian, and Jake Conley discuss UnitedHealth (UNH) reporting third quarter earnings results that beat Wall Street's expectations and raised its full-year profit outlook.",
                "category": "company",
                "datetime": 1791898073,
                "headline": "UNH beats Q3 expectations, raises guidance as AI helps cut costs"
              },
              {
                "id": 142848751,
                "url": "https://finnhub.io/api/news?id=48a163eb8533caa425a6a80467bece28a795de9de6889d3d75af71e5433da61b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth crushed earnings estimates and lifted its full-year outlook, but the number driving its medical cost improvement raises a critical question about whether the turnaround is built to last.",
                "category": "company",
                "datetime": 1791897956,
                "headline": "UnitedHealth Rises 4% on Earnings Beat and Raised Full-Year Outlook; Humana Advances 2%"
              },
              {
                "id": 142848752,
                "url": "https://finnhub.io/api/news?id=b7b35ab5c9399c13af549b784b36d08c2f629f0fade79e537c75a275b0f70828",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The Dow giant's profits have recovered as medical membership has fallen.",
                "category": "company",
                "datetime": 1791896940,
                "headline": "UnitedHealth Cost Comments Fuel Dow Jones Stock To Key Level"
              },
              {
                "id": 142846062,
                "url": "https://finnhub.io/api/news?id=eec09f31d904397965fda99708f419d78db259c5f22148d9149b02c985cd4486",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) said Tuesday that it has agreed to form a joint venture with funds managed by BlackRock",
                "category": "company",
                "datetime": 1791888909,
                "headline": "Humana Forms Joint Venture With BlackRock for 150 Senior Care Clinics"
              },
              {
                "id": 142844761,
                "url": "https://finnhub.io/api/news?id=4a972e36ad6dc1f0ff909eac7fa1f19b59b1e2c4914de0984f257ed664040db1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., October 13, 2026--Humana Inc. (NYSE: HUM) today announced it has entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a part of BlackRock (\"BlackRock\"), to manage and operate an existing network of nearly 150 CenterWell Senior Primary Care clinics that currently sit within joint ventures owned by funds affiliated with WCAS and CenterWell. The new joint venture, majority owned by BlackRock and minority owned by CenterWell, will re",
                "category": "company",
                "datetime": 1791886920,
                "headline": "Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics"
              },
              {
                "id": 142847499,
                "url": "https://finnhub.io/api/news?id=f0427855a084fa46afb0d647861623136af4746969ce5593a6ff292a265f2fa5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) delivered earnings and revenue surprises of +13.84% and +1.18%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1791885902,
                "headline": "UnitedHealth Group (UNH) Q3 Earnings and Revenues Top Estimates"
              },
              {
                "id": 142848953,
                "url": "https://finnhub.io/api/news?id=0fce12761cb80be6603357d56e0cdfdedb64a8ca0942f5b6d4524d7dee02db4d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/13/Crypto-Trader-Investor-Broker-Using-Smar.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Analysts cut targets for Duke, Hyatt, Pershing Square, Carlisle, Upstart, Arch Capital and Meta; raised VF, Rexford and SentinelOne.",
                "category": "company",
                "datetime": 1791880215,
                "headline": "Humana To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Tuesday"
              },
              {
                "id": 142849350,
                "url": "https://finnhub.io/api/news?id=4ab1a71e3b41731a9b599a7a73d1dba914c2a9c9d60c30c376783377ff5f810d",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Mizuho  analyst Ann Hynes   maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $468 to $495.",
                "category": "company",
                "datetime": 1791879758,
                "headline": "Mizuho Maintains Outperform on Humana, Raises Price Target to $495"
              },
              {
                "id": 142848465,
                "url": "https://finnhub.io/api/news?id=b1f3e8043192af47f98124a544c425be42a9a21c3e0b5dcc2631ec05d13bc36f",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana Inc. (the "Company") issued a press release today reporting its entry into a new joint venture arrangement with funds and accounts managed by HPS Investment Partners, a subsidiary of BlackRock, Inc.",
                "category": "company",
                "datetime": 1791871891,
                "headline": "Humana Forms JV With BlackRock To Manage And Operate Existing Network Of CenterWell Senior Primary Care Clinics; Reaffirms FY26 Adjusted EPS Guidance"
              },
              {
                "id": 142838692,
                "url": "https://finnhub.io/api/news?id=c0cb74b0327546aac69c50cf61be849d3baf17e2977eca3b48ca4d061f87e574",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Tidal Financial Group strategist Michael Khouw says options imply a 6.5% earnings move, with implied volatility at 40%, twice the stock’s realized volatility.",
                "category": "company",
                "datetime": 1791871778,
                "headline": "UNH Stock Rises Overnight Ahead Of Earnings: Analyst Outlines ‘Short Premium’ Play To Cut January Call Cost By Nearly 60%"
              },
              {
                "id": 142824645,
                "url": "https://finnhub.io/api/news?id=24972eb42372f8d2043a41f92db5ec599632f42f62852b088e3a888295d3712f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., October 12, 2026--Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2026 (3Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 6, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.",
                "category": "company",
                "datetime": 1791837000,
                "headline": "Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026"
              },
              {
                "id": 142823708,
                "url": "https://finnhub.io/api/news?id=76c279f40b2ea3c9822b1d1ce2e3344b47316d325ee958932b5df2cc915af9cf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investing.com -- Managed care insurers face divergent earnings impacts from the Centers for Medicare and Medicaid Services' 2027 Star Ratings, with Humana positioned for significant upside while UnitedHealth confronts the largest headwind, according to an Evercore note to clients from analyst Elizabeth Anderson following the CMS release.",
                "category": "company",
                "datetime": 1791834344,
                "headline": "Humana leads Managed Care winners in new CMS Star Ratings - Evercore"
              },
              {
                "id": 142823813,
                "url": "https://finnhub.io/api/news?id=a43a22a16072cca6c4d59306f0111e72c743c74abf96ea1b7bf78760e3178f70",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "On October 9, Humana Inc. (NYSE:HUM) gained more than 11% after analysts named it the biggest potential beneficiary of the new Medicare Advantage star ratings for 2027. Earlier this year, the stock also ranked 5th on our list of the 7 Best Turnaround Stocks to Buy in 2026. See which four stocks ranked higher than […]",
                "category": "company",
                "datetime": 1791830349,
                "headline": "Humana (HUM) Gets a Major Ratings Boost. Can Earnings Justify the Valuation?"
              },
              {
                "id": 142823814,
                "url": "https://finnhub.io/api/news?id=c38a1fd70c073e2aa7ff4cca514382b82259cdbb678f2719e82c423d41ad1616",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.",
                "category": "company",
                "datetime": 1791825120,
                "headline": "Strength Seen in Humana (HUM): Can Its 11.6% Jump Turn into More Strength?"
              },
              {
                "id": 142849352,
                "url": "https://finnhub.io/api/news?id=e46cfd9b0c499f29c2fc5937e60cc191233f40179bd611568c9e7046a99fc17c",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "UBS  analyst A.J. Rice   maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $405 to $495.",
                "category": "company",
                "datetime": 1791825004,
                "headline": "UBS Maintains Neutral on Humana, Raises Price Target to $495"
              },
              {
                "id": 142821860,
                "url": "https://finnhub.io/api/news?id=4b07aecf0b4f84e4a06de04c1e551560a219a6d898257a98f8d48a00434947d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DataMeds AI’s Helomics subsidiary has received a Medicaid coverage determination under Humana’s policy, potentially expanding reimbursement access for its precision oncology test while supporting commercial growth. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) has secured a Medicaid coverage determination for its ChemoFx Assay through subsidiary Helomics Corporation.",
                "category": "company",
                "datetime": 1791816513,
                "headline": "DataMeds AI Secures Medicaid Coverage for ChemoFx Assay in Gynecologic Cancers"
              },
              {
                "id": 142821660,
                "url": "https://finnhub.io/api/news?id=211af12e3732a278657f2c71d03dd93048a232b99b048293b2fb0bf1d6c6b903",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana's 2027 Medicare Advantage ratings rebound puts 95% of members in four-star or better plans, potentially boosting 2028 bonus payments and plan benefits.",
                "category": "company",
                "datetime": 1791814860,
                "headline": "Humana Hits 95% Four-Star Coverage: What it Means for HUM"
              },
              {
                "id": 142849353,
                "url": "https://finnhub.io/api/news?id=19bc9afb3640746e1aefb46523f63e62d6583b2bafe9021c2b1aecc2f3f282a7",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Truist Securities  analyst David Macdonald   maintains Humana (NYSE:HUM) with a Hold and raises the price target from $415 to $475.",
                "category": "company",
                "datetime": 1791814552,
                "headline": "Truist Securities Maintains Hold on Humana, Raises Price Target to $475"
              },
              {
                "id": 142849354,
                "url": "https://finnhub.io/api/news?id=00cc3d2e4b635b2089af34dd3994917d0824ce02579bde381796f2e237cb4308",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Oppenheimer  analyst Michael Wiederhorn   maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $475 to $525.",
                "category": "company",
                "datetime": 1791812704,
                "headline": "Oppenheimer Maintains Outperform on Humana, Raises Price Target to $525"
              },
              {
                "id": 139933529,
                "url": "https://finnhub.io/api/news?id=3f89e8879d586e5cd629005d198da398df5b90ad7a78af13079c92adb0c779d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1791812513,
                "headline": "Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls"
              },
              {
                "id": 142819561,
                "url": "https://finnhub.io/api/news?id=ffc773d334efe624c663a0d465084aadbb1e41284edafb8a5fc4ab1ca4d5e246",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1791811325,
                "headline": "Raymond James Upgrades Humana to Outperform from Market Perform"
              },
              {
                "id": 142819793,
                "url": "https://finnhub.io/api/news?id=ad36772a02042682f8385c327ab763f735b1ca840883528dd0b4721bc88b82d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Companies in The News Are: HUM, LITE, MSTR, AAPL",
                "category": "company",
                "datetime": 1791808080,
                "headline": "Company News for Oct 12, 2026"
              },
              {
                "id": 142849355,
                "url": "https://finnhub.io/api/news?id=2c95699d38bcdfcbd88705e7fddb2af80a23cc90019bf2bd520d83262a86a4ae",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/12/Medical-Technology--Doctor-Use-Ai-Robots.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana includes DataMeds AI's Helomics ChemoFx assay in its Medicaid policy for gynecologic cancers, expanding payer reimbursement.",
                "category": "company",
                "datetime": 1791806434,
                "headline": "DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test"
              },
              {
                "id": 142818995,
                "url": "https://finnhub.io/api/news?id=a0322560b8e7f90c21b9ad6b298aad238f6dff74eb86d9dc9103144495942531",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "American News Group News Commentary - The S&P 500 set an all-time high on Tuesday, October 6, and finished the week at 7,811.54 after a Friday gain of 0.6%, with the Dow Jones Industrial Average closing at 51,654.95 and the Nasdaq Composite at 27,366.17. All three finished the week higher, even as the 10-year Treasury yield recently reached its highest level since 2002 and closed Friday at 5.24%. The most active names of the week moved on company news: a satellite spectrum deal that hit wireless",
                "category": "company",
                "datetime": 1791804540,
                "headline": "After a Record-Setting Week, Wall Street Turns to Inflation Data and the First Big Earnings Reports"
              },
              {
                "id": 142817188,
                "url": "https://finnhub.io/api/news?id=ee739bf84a4f715b2d21a66a356c59d38db333346ac973fc897977f53461d1d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policyTAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc. Medical Coverage Policies were reviewed by Humana's Medicaid Coverage Policy Adoption (MCPA) Forum, which incorporated the ChemoFx Assay in its Coverage Determination for Pharmacogenomics Testing[1].",
                "category": "company",
                "datetime": 1791799200,
                "headline": "DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers"
              },
              {
                "id": 142815584,
                "url": "https://finnhub.io/api/news?id=92f35ca77b3b4365a34648301d4adb104b1a0e13ec54e6107426ad61520ac1a5",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_733ebd5e0f.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "SpaceX’s spectrum deal wiped double digits off T-Mobile, AT&T and Verizon while tower stocks soared. Stocks still closed a volatile week higher, despite 24-year highs in long-term yields, weaker consumer sentiment, Apple’s iPhone order cuts and a hurricane shutting in Gulf oil output.",
                "category": "company",
                "datetime": 1791793337,
                "headline": "Starlink Goes Mobile, and Wall Street Rewrites the Telecom Map Overnight"
              },
              {
                "id": 142820986,
                "url": "https://finnhub.io/api/news?id=85f0191e1f300cb29c61a6c56e206106cf5dcd59624ea7e0f8ff947e72bff890",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Raymond James  analyst John Ransom   upgrades Humana (NYSE:HUM) from Market Perform to Outperform and announces $520 price target.",
                "category": "company",
                "datetime": 1791789958,
                "headline": "Raymond James Upgrades Humana to Outperform, Announces $520 Price Target"
              },
              {
                "id": 142811129,
                "url": "https://finnhub.io/api/news?id=aa4e6af2649f3f9eeb6605ff7b67664cda878a49a5317f2d94fbdf632020f8e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The rallies highlighted growth opportunities across biotechnology, health insurance and optical technology.",
                "category": "company",
                "datetime": 1791774188,
                "headline": "Why Did MRNA, HUM, LITE Stocks Surge To 52-Week Highs Last Week?"
              },
              {
                "id": 142820987,
                "url": "https://finnhub.io/api/news?id=9af20342499f6ff34a8e09367e2326336d883082053912c86a76fa32149875c3",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/12/Fear-and-Greed.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "CNN Fear & Greed Index rose to Neutral at 45 as U.S. stocks gained Friday; Dow jumped 423 points, while consumer sentiment weakened.",
                "category": "company",
                "datetime": 1791772966,
                "headline": "Dow Jumps Over 400 Points, Records Weekly Gain: Investor Sentiment Improves, Fear & Greed Index Moves yo ‘Neutral’ Zone"
              },
              {
                "id": 142807844,
                "url": "https://finnhub.io/api/news?id=90ca36d611d7aa1dd8115050086740c46fc849ce2d3869cdf35f5d3948fe4662",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "A federal protection program opens for affected retirees, but the window won’t last long.",
                "category": "company",
                "datetime": 1791743580,
                "headline": "Suze Orman warns 390,000 seniors on Medicare plan exit"
              },
              {
                "id": 142805891,
                "url": "https://finnhub.io/api/news?id=d991bc7a346c5d852ea615a063556d870477ec3948eca14fe5cc37532ff1c7f6",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1163752700/image_1163752700.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Humana stock: efficiency gains and better Star Ratings, but margins/cash flow pressured. Click for more on HUM stock.",
                "category": "company",
                "datetime": 1791712800,
                "headline": "Humana's Star Ratings Progress Doesn't Erase Valuation Concerns"
              },
              {
                "id": 142773399,
                "url": "https://finnhub.io/api/news?id=baacacd7f6627bbc95e2292de15e100e01688f41649edba643a5ca47e1b12cc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "In early October 2026, BlueWind Medical announced that Humana began covering implantable tibial neuromodulation therapy for urgency urinary incontinence, including BlueWind’s Revi System, across its Medicare Advantage membership of about 11 million enrollees. This coverage decision, backed by multi‑year OASIS clinical data and a new AMA Category I CPT code for subfascial tibial neuromodulation, highlights how Humana may be broadening access to advanced, home‑managed therapies for seniors...",
                "category": "company",
                "datetime": 1791591288,
                "headline": "Humana (HUM) Deepens MA Neuromodulation Coverage: A Clue to Its Margin Recovery Strategy?"
              },
              {
                "id": 142768092,
                "url": "https://finnhub.io/api/news?id=1cab6596c18b84afa417c87209d7f9bd1c6eb2fb19b06bb0b97418f5368caea9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Shares of health insurance company Humana (NYSE:HUM) jumped 16.8% in the pre-market session after Robert W. Baird upgraded the company to Outperform from Neutral and raised its price target to $596 from $390, following an operational recovery in federal quality ratings.",
                "category": "company",
                "datetime": 1791584350,
                "headline": "Humana (HUM) Stock Trades Up, Here Is Why"
              },
              {
                "id": 142767148,
                "url": "https://finnhub.io/api/news?id=317e2a4ac9bd7cae9e89e143d2b9dc3ccea939aa2979a3895e46147f424bc6e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index up 1.2% and the State S",
                "category": "company",
                "datetime": 1791575829,
                "headline": "Sector Update: Healthcare Stocks Gain Late Afternoon"
              },
              {
                "id": 142766401,
                "url": "https://finnhub.io/api/news?id=612d38a2cd3650db57493c5fd2f75e23054041ae80e897b8c7b95d2d173e8119",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "US health insurance and managed care stocks were mostly advancing Friday, with Humana (HUM) surging",
                "category": "company",
                "datetime": 1791575519,
                "headline": "Humana Shares Surge Following Significant Medicare Advantage Star Ratings Improvement"
              },
              {
                "id": 142765953,
                "url": "https://finnhub.io/api/news?id=fa69fc8000049deee244f45ce89b56b001c6c1c2df31ee60616bdbf8d43bd682",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1791572701,
                "headline": "Discover which S&P500 stocks are making waves on Friday."
              },
              {
                "id": 142765272,
                "url": "https://finnhub.io/api/news?id=bbe1f2ebcbdec19b2d3d7a9225e75ca95b9ff0d43fd56d4c93f423c792c747fa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index up 1.2% and the State Street",
                "category": "company",
                "datetime": 1791568225,
                "headline": "Sector Update: Healthcare Stocks Gain Friday Afternoon"
              },
              {
                "id": 142765282,
                "url": "https://finnhub.io/api/news?id=9e7332cc74618b03804573ae8b7a0fc7855c0c6adf03785ef48ba630a6291f3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) leads the managed care sector in the Centers for Medicare & Medicaid Services' 2027 Med",
                "category": "company",
                "datetime": 1791566622,
                "headline": "Humana Leads Managed Care Peers in 2027 Medicare Advantage Star Ratings, Deutsche Bank Says"
              },
              {
                "id": 142766847,
                "url": "https://finnhub.io/api/news?id=dc6fe86535528a99884f6b0d58de61bd029043fe1794826110f6b931d25e9787",
                "image": "https://static.seekingalpha.com/uploads/2026/10/9/36131525-1791573558807229_origin.png",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Humana surged after its main Medicare Advantage contract regained a 4-star CMS rating for 2027, a major profit catalyst. Read more on HUM stock here.",
                "category": "company",
                "datetime": 1791565870,
                "headline": "Humana Surges On 2027 CMS Ratings, Technical Breakout, Shares Fairly Priced"
              },
              {
                "id": 142764758,
                "url": "https://finnhub.io/api/news?id=95482707e72d2d971bc9d095a74ac57ded6f10fa73640163075db599299cdd21",
                "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Let's have a look at the S&P500 stocks with an unusual volume in today's session.",
                "category": "company",
                "datetime": 1791565500,
                "headline": "Which S&P500 stocks have an unusual volume on Friday?"
              },
              {
                "id": 142765175,
                "url": "https://finnhub.io/api/news?id=e2913beaadf1db3f33833ef61fbced7dc4133c9337ea40b3444fbd6e500ae4fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "On Oct. 9, 2026, major benchmarks recover from earlier volatility as AI jitters and geopolitical tensions ease.",
                "category": "company",
                "datetime": 1791564288,
                "headline": "Stock Market Midday, Oct. 9: Stocks Edge Higher, Humana jumps 13%"
              },
              {
                "id": 142765283,
                "url": "https://finnhub.io/api/news?id=edb054724b2702fdca66d731b35ded5ece05d8b63c228981d02e1d9bc994052c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Aetna, the insurance arm of CVS Health, saw its four-star or higher plans lose ground in the latest federal ratings.",
                "category": "company",
                "datetime": 1791561540,
                "headline": "CVS Stock Dips After Drop in Medicare Advantage Plan Ratings"
              },
              {
                "id": 142765281,
                "url": "https://finnhub.io/api/news?id=e5e35a8b3c0ded3348c1b0f24165566586631a0c99a7b4d3b4d36dd1cff38ba8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH's diversified healthcare platform, improving Medicare Advantage profitability and lower valuation give it an edge over HUM.",
                "category": "company",
                "datetime": 1791560760,
                "headline": "UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge?"
              },
              {
                "id": 142764093,
                "url": "https://finnhub.io/api/news?id=20318a2d3e6eee7eee4ab5ca76a3712ed8fe60270659813ee0c755002a3fed89",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "A $0 premium plan sounds like a win until the number that actually pads your Social Security deposit quietly disappears. Here is what Humana changed for 2027 and what a retired person on a fixed income stands to lose each month without realizing it.",
                "category": "company",
                "datetime": 1791559989,
                "headline": "At 71, She Chose Humana for the Part B Giveback in Her Social Security Check. For 2027, Humana Will Cut or Eliminate It for 62% of Those Members"
              },
              {
                "id": 142764092,
                "url": "https://finnhub.io/api/news?id=bb3bb105811cdb2ac3132dd22b20d53692c49bb773491f659a6a1aa3baa87548",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CMS just reshuffled Medicare Advantage star ratings, and the fallout is splitting major insurers into winners and losers almost overnight. Before you assume the quality of senior care is actually improving or collapsing, there is a crucial wrinkle in how the scores were calculated that changes everything.",
                "category": "company",
                "datetime": 1791558525,
                "headline": "Seniors Face an 18% Drop in Highly Rated Medicare Advantage Plans — But Quality Might Not Be the Cause"
              },
              {
                "id": 142763984,
                "url": "https://finnhub.io/api/news?id=7943a40a53d00db88dfcbab83cac62ba2c53e417ec30daf248aba4fa14449e6e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "On this episode of Stock Movers: - Delta (DAL) shares are sliding after the company reduced its full-year earnings outlook due to high jet fuel prices stemming from the war in the Middle East. - Humana (HUM) is surging as the company improved its performance on crucial Medicare Advantage quality ratings that will boost future revenue. Shares of CVS meanwhile fell as ratings for some of its largest plans deteriorated, while UnitedHealth shares were little changed in premarket trading. - Apple (AAPL) shares are slipping after a report that the company cut component orders for the iPhone 18 Pro and iPhone 18 Pro Max following weaker-than-expected demand.",
                "category": "company",
                "datetime": 1791557910,
                "headline": "Delta Slides on FY Outlook; Humana Surges on Quality Ratings | Stock Movers"
              },
              {
                "id": 142763152,
                "url": "https://finnhub.io/api/news?id=4ba6faa54aeae86cd69686eb99446787aeed25e8fac8408f5f1797664b3f643a",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1791556200,
                "headline": "Gapping stocks in Friday's session"
              },
              {
                "id": 142764310,
                "url": "https://finnhub.io/api/news?id=4d437e08fe466ed541bd5eef3750781e68f087ceaed459ad89e1ceddd5089ffb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s assessed fair value has shifted from US$419.04 to US$430.70 per share, giving investors an updated price anchor to compare with current trading levels. This adjustment aligns with recently more active research coverage, as analysts recalibrate targets while they reassess Medicare Advantage margins, cost trends and the potential impact of upcoming star ratings cycles. Read on to see how these evolving views on Humana could shape expectations and how you can keep track of the changing...",
                "category": "company",
                "datetime": 1791555246,
                "headline": "Humana (HUM) Stock Fair Value Edges Higher After Analyst Target Revisions"
              },
              {
                "id": 142764311,
                "url": "https://finnhub.io/api/news?id=2bcca589a783a3365f697cbba751f98c4285a8e2e765616abc99c2e4e6755b05",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM:NYSE) shares are up about 15% this morning (trading at about $447) after the insurer said 95% of its Medicare Advantage members will be in plans rated four stars or higher for 2027. A year ago, that figure was just 20%.",
                "category": "company",
                "datetime": 1791555208,
                "headline": "Humana Soars 15% on Medicare Star Ratings: “95% of Members in Four-Star Plans”"
              },
              {
                "id": 142761617,
                "url": "https://finnhub.io/api/news?id=8019c880fe0c4a00f7e9abe7cfb5f19d0f21c3d8f821c1d3a92e1d163987cecd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "SpaceX initiated, Humana upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1791553518,
                "headline": "SpaceX initiated, Humana upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 142764312,
                "url": "https://finnhub.io/api/news?id=22a2ec5da2a9666a2ef770e87e34ca21b6a9fe7b1033cd4bd952d0b7c6134c29",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana shares are soaring after the health insurer said it received improved star ratings for a number of its Medicare Advantage plans.",
                "category": "company",
                "datetime": 1791553473,
                "headline": "Humana Stock Jumps on Raised Medicare Advantage Ratings"
              },
              {
                "id": 142791247,
                "url": "https://finnhub.io/api/news?id=6d6a7f613588e29781ea47aa1622e652afe48f306894f204f475dfe565f02ff3",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/09/Los-Angeles--California--May-20--2024-T-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "The Nasdaq 100 recovers from Thursday's OpenAI-driven selloff while T-Mobile sinks 12% on SpaceX's spectrum deal and the 10-year yield holds near 5.26%.",
                "category": "company",
                "datetime": 1791552427,
                "headline": "Stock Market Today: Nasdaq 100 Rebounds From OpenAI Scare, T-Mobile Tumbles 12%"
              },
              {
                "id": 142761965,
                "url": "https://finnhub.io/api/news?id=4c3a81f75d33d8c661da1f5214a3734781c46ff75eabc35496a2e49d3c660b79",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health insurer said 95% of its Medicare Advantage members will be in plans rated 4 stars or higher in 2027, up from 20% in 2026",
                "category": "company",
                "datetime": 1791552348,
                "headline": "Humana stock rises 15% after Medicare star ratings jump"
              },
              {
                "id": 142791255,
                "url": "https://finnhub.io/api/news?id=2b02ae29377f30278e4ddcc4362138d9dd5e2ab1d4086c3a52956994f67691ce",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/09/A-Lot-Of-Gold-Bars.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "U.S. stocks rose Friday, led by the Dow and Nasdaq; sentiment hit a five-month low, while Veea and WF Holding surged and T-Mobile fell.",
                "category": "company",
                "datetime": 1791551838,
                "headline": "Gold Rises Over 1%; US Consumer Sentiment Falls"
              },
              {
                "id": 142761648,
                "url": "https://finnhub.io/api/news?id=f579421557b632f0a8b76ca9e5870d86d7bccecb8743bbf252acc2dd567927f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "During an August 5, 2026 call, management at Clover Health Investments (CLOV) noted that nearly half of its Medicare Advantage members joined the company in 2025 or 2026. That matters because Clover typically earns less gross profit on a member in the first year than in the second, and the 2026 cohort is still navigating that initial period. Even so, the stock has returned 70% over the past twelve months, compared to 17.0% for the S&P 500. So where are all these new members coming from.",
                "category": "company",
                "datetime": 1791551639,
                "headline": "Is Clover Health Stock Too Dependent On One Group Of Members?"
              },
              {
                "id": 142764313,
                "url": "https://finnhub.io/api/news?id=33741abb4054391c93ab4a7458ea3e6f1d561b1b92821e2c98dd1c137bd38710",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) shares were up nearly 15% on Friday after the company improved its Medicare Advantage quality ratings for 2027. Around 95% of members enrolled in plans rated at least four stars, strengthening its position ahead of the annual enrollment period. The company reported that...",
                "category": "company",
                "datetime": 1791551520,
                "headline": "Humana raises Medicare Advantage ratings as 95% of members qualify for 4-star plans"
              },
              {
                "id": 142761972,
                "url": "https://finnhub.io/api/news?id=5bf7ac9cea3953537b3ed21e6e9d284e970fd05a2e698dd21d66c798a89bd23a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Key TakeawaysAlignment Healthcare shares fell 20% after its California HMO contract, which serves about 75% of its health plan members, dropped to 3. 5 stars from 4.",
                "category": "company",
                "datetime": 1791551507,
                "headline": "Alignment Healthcare Sinks 20% as Medicare Plan Downgraded (Humana and Clover Soar)"
              },
              {
                "id": 142764146,
                "url": "https://finnhub.io/api/news?id=a09c265d8156e27c505ea916b11533d9e7442cd4cce7ef8aca6e9a6930bb3b21",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "SpaceX rises after the company places its bets on potentially becoming a major mobile carrier in the U.S.",
                "category": "company",
                "datetime": 1791551220,
                "headline": "SpaceX, AT&T, Crown Castle, Delta, Humana, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 142761966,
                "url": "https://finnhub.io/api/news?id=95ad9e370f4ea8dd63a9fa48da124324fdf73243f0f07b4d0f7b77b941d9a27c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "A Healthcare Dive analysis of highly anticipated stars data shows a mixed bag of winners and losers, though — as expected — the quality scores slipped overall. See how major carriers fared for 2027.",
                "category": "company",
                "datetime": 1791551119,
                "headline": "Humana soars, Alignment plummets in 2027 Medicare Advantage star ratings"
              },
              {
                "id": 142764935,
                "url": "https://finnhub.io/api/news?id=be6d0aae3c502dca51f77ac1b7c6e4cfaae019e2214c34345accaf3643ef70a8",
                "image": "https://image.cnbcfm.com/api/v1/image/108382338-17915650141791565012-48893047759-1080pnbcnews.jpg?v=1791565013&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "CNBC's Annika Kim Constantino joins 'Halftime Report' to report on Humana and other insurance companies.",
                "category": "company",
                "datetime": 1791550840,
                "headline": "Insurers on the move: Here's what you need to know"
              },
              {
                "id": 142761647,
                "url": "https://finnhub.io/api/news?id=71d042b9ca9a3a4f155550a980d49c6070304e06cfb993f6d63bf0d3f75833c1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "A single Medicare quality ratings release sent one major insurer soaring while dragging a rival into the red, and the gap between winners and losers points to something deeper than a routine scoring update.",
                "category": "company",
                "datetime": 1791549722,
                "headline": "Humana Soars 16% on Improved Medicare Advantage Star Ratings; CVS Slides 3%, UnitedHealth Holds Steady"
              },
              {
                "id": 142761968,
                "url": "https://finnhub.io/api/news?id=b5a9e1d54f00f43dcaf5198b9005e75a98640cf5da4dc3d609e87031b6b11569",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) reported that 95% of its Medicare Advantage members are enrolled in plans receiving quality ratings of at least four stars from the Centers for Medicare & Medicaid Services (CMS) for 2027, marking an improvement from the previous year. The US health insurer said 42% of its Medicare Advantage membership is covered by plans awarded 4.",
                "category": "company",
                "datetime": 1791549438,
                "headline": "Humana Says 95% of Medicare Advantage Members Are Enrolled in Plans Rated Four Stars or Higher for 2027"
              },
              {
                "id": 142760962,
                "url": "https://finnhub.io/api/news?id=778ceffa164e9c35d0e2b24a8f102c642d824f901e9fc3094deeb6e3b2074f5a",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session.",
                "category": "company",
                "datetime": 1791549302,
                "headline": "Get insights into the top movers in the S&P500 index of Friday's pre-market session."
              },
              {
                "id": 142760960,
                "url": "https://finnhub.io/api/news?id=c970fbe5a697f3f44e82cb6e83e5c0608d464bfe6fed78f2fcb8568448e196fd",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.",
                "category": "company",
                "datetime": 1791549000,
                "headline": "These stocks are moving in today's pre-market session"
              },
              {
                "id": 142761773,
                "url": "https://finnhub.io/api/news?id=600eaec27f911dac93ca057dfe3003f119408f1ebd25c2dc470dce74cbbcf8d9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana and Clover soared after their Medicare Advantage plans earned higher Star Ratings. CVS Health and Alignment Healthcare tanked on Friday after their plans got downgraded.",
                "category": "company",
                "datetime": 1791548958,
                "headline": "Humana, Clover Soar On Medicare Advantage Star Rating; These Stocks Sink"
              },
              {
                "id": 142761970,
                "url": "https://finnhub.io/api/news?id=58362ebaacc8d7431ddc8c23d552140738174c706d57c61b103a6cc22c25f1bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investing.com - U.S. stock futures were broadly higher on Friday as investors weighed debate over OpenAI’s revenue outlook, while oil prices eased after President Donald Trump said the U.S. would not launch new attacks on Iran before the November midterm elections.",
                "category": "company",
                "datetime": 1791547682,
                "headline": "Premarket movers: Humana rallies; SpaceX deal sends telco stocks down"
              },
              {
                "id": 142760964,
                "url": "https://finnhub.io/api/news?id=f438f40a3e864814c234eabb487fb1de7c34ce9141e20db7bb9a7f4ea6adfdca",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1791547043,
                "headline": "Baird Upgrades Humana to Outperform from Neutral"
              },
              {
                "id": 142761971,
                "url": "https://finnhub.io/api/news?id=f04e8e2a3f671a8880cf7ea6eae3ff7f5c137e20b602d3f0d326ff128cd40255",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s improved Medicare Advantage star ratings strengthen its eligibility for 2028 quality bonus payments, while analysts see potential for an earnings recovery.",
                "category": "company",
                "datetime": 1791546850,
                "headline": "Humana Gets Bullish Calls From Baird, Barclays On Medicare Advantage Recovery"
              },
              {
                "id": 142761493,
                "url": "https://finnhub.io/api/news?id=b2e24e9becfec1d249f3abe894eb88f2f1a372a49c3948db0d1e7b10b5723679",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Tech stocks are rebounding helped by falling oil prices but the AI trade is exposed.",
                "category": "company",
                "datetime": 1791545880,
                "headline": "AI Stocks Are Roaring Back but They’ve Rarely Looked So Vulnerable"
              },
              {
                "id": 142760653,
                "url": "https://finnhub.io/api/news?id=6e86f4bd4a776c2722e660026e7503acb21cfa4e31bfa76339d552f31eb93b16",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS’ share of Medicare Advantage members in plans rated at least 4.5 stars is expected to drop sharply to 35% from 63%, TD Cowen said.",
                "category": "company",
                "datetime": 1791545833,
                "headline": "CVS Stock: TD Cowen Warns Of Bottom-Line Pressure For CVS Health Amid Star Ratings Setback"
              },
              {
                "id": 142763365,
                "url": "https://finnhub.io/api/news?id=e8a33e2e34eb5ad9a85389b5450190ce06b03de47ad677f6b29818663259167f",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/09/Stuttgart--Germany---07-28-2023-Person-H.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaffirmed FY26 EPS guidance.",
                "category": "company",
                "datetime": 1791543065,
                "headline": "Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday"
              },
              {
                "id": 142792238,
                "url": "https://finnhub.io/api/news?id=26fdd23a8454592b9179ad1b74c73d96d89f41aaa0bbc2ae6b003ef3f9b7c714",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Barclays  analyst Andrew Mok   maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $515 to $582.",
                "category": "company",
                "datetime": 1791542782,
                "headline": "Barclays Maintains Overweight on Humana, Raises Price Target to $582"
              },
              {
                "id": 142764779,
                "url": "https://finnhub.io/api/news?id=0a3f3699c836610c17552d7e2dddb0e06a41e7e99eb2a3f2dde5510206523f9b",
                "image": "https://image.cnbcfm.com/api/v1/image/108381791-6ED1-REQ-100926-NewsOPEN.jpg?v=1791554819&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "CNBC brings you fast, accurate, and actionable business news and market updates.",
                "category": "company",
                "datetime": 1791540647,
                "headline": "Market Open: October 9, 2026"
              },
              {
                "id": 142760702,
                "url": "https://finnhub.io/api/news?id=86583c81e871292bbf2d8be5e5e7a942e6460edb2b232edaaab88ce8ea165e1e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., October 09, 2026--Humana Inc. (NYSE: HUM), a leading consumer healthcare company focused on helping people achieve their best health, today announced improved Star Ratings for 2027, highlighted by 95% of its Medicare Advantage members being enrolled in plans rated 4.0 stars or above by the Centers for Medicare and Medicaid Services (CMS). Additionally, 42% of Humana Medicare Advantage members are enrolled in 4.5-star plans for 2027.",
                "category": "company",
                "datetime": 1791540600,
                "headline": "Humana Announces Improved CMS Star Ratings with 95 Percent of Medicare Advantage Members in 4-Star or Above Plans for 2027"
              },
              {
                "id": 142792239,
                "url": "https://finnhub.io/api/news?id=82e0b46371accdb6a35eafa9fd97e0f5b70d12f9199d39effca2ceea9b35e7b2",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Oppenheimer  analyst Michael Wiederhorn   maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $405 to $475.",
                "category": "company",
                "datetime": 1791540298,
                "headline": "Oppenheimer Maintains Outperform on Humana, Raises Price Target to $475"
              },
              {
                "id": 142761394,
                "url": "https://finnhub.io/api/news?id=08e57d86273ff960371a40e18389e8b7e946cb0a91a8d68150887730127b5937",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/09/Louisville--Kentucky--Usa---December-28-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana’s 2027 Medicare Advantage Star Ratings jump, with 95% of members in 4+ star plans. HUM shares surge in premarket trading.",
                "category": "company",
                "datetime": 1791538659,
                "headline": "Humana Stock Hits 52-Week High After Medicare Ratings Boost"
              },
              {
                "id": 142761246,
                "url": "https://finnhub.io/api/news?id=456464d1145ca9b8194cd0a4c28b62e3afa7a2f7d4836eed58c833c24d595c4b",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/09/Wall-Street.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "U.S. stock futures were higher on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's mixed close.",
                "category": "company",
                "datetime": 1791537701,
                "headline": "Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Scott Bessent Says US Is Starving Iran's 'Tyrannical Regime'— PKE, HUM, RENX in Focus (UPDATED)"
              },
              {
                "id": 142761381,
                "url": "https://finnhub.io/api/news?id=d2532159d2519f8a84debe6570d937118d333e71b3f68bc98a08ed16d50e1662",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/09/CrowdStrike.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Analysts raised targets for HOOD, SAIL, U and CRWD; cut targets for BULL, ALGN and PCRX, with PCRX downgraded to Neutral.",
                "category": "company",
                "datetime": 1791537104,
                "headline": "CrowdStrike To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday"
              },
              {
                "id": 142761397,
                "url": "https://finnhub.io/api/news?id=5c05dce0932f537f7771ef0add981c7ff467d92ba9a49900a69ffbd05859376a",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/09/Stuttgart--Germany---07-28-2023-Person-H.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Analysts upgraded Humana, Cboe, Jack Henry, Fastly, raising ratings and targets, including HUM to $596 and CBOE to $358.",
                "category": "company",
                "datetime": 1791534899,
                "headline": "This Humana Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday"
              },
              {
                "id": 142761234,
                "url": "https://finnhub.io/api/news?id=cdf863a062aea1491c801100873531d2846bb86cc5045687a32fe1a61b587f14",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Gainers\n\nHumana (NYSE:HUM) stock moved upwards by 16.2% to $450.0 during Friday's pre-market session. The market value of their outstanding shares is at $46.4 billion. \nXORTX Therapeutics (NASDAQ:XRTX) shares",
                "category": "company",
                "datetime": 1791533140,
                "headline": "12 Health Care Stocks Moving In Friday's Pre-Market Session"
              },
              {
                "id": 142761399,
                "url": "https://finnhub.io/api/news?id=42f9e1bceebbd0966676fbafd87be687ced840ce5c6d0a016b6395a3dc8adfdf",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana (NYSE:HUM) FY2026  expected to be more than $9.00 vs $9.15 Est..",
                "category": "company",
                "datetime": 1791531448,
                "headline": "Humana FY2026  Adj EPS expected to be more than $9.00 vs $9.15 Est"
              },
              {
                "id": 142761400,
                "url": "https://finnhub.io/api/news?id=cb9edbedbe00537d122d9c8d40a8e7a359b839c23611f997b461d95140f4b065",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Humana affirms its guidance of at least $9.00 in adjusted earnings per common share ("Adjusted EPS"), for the year ending December 31, 2026 ("FY 2026"). This guidance is consistent with the guidance",
                "category": "company",
                "datetime": 1791526284,
                "headline": "Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To Shareholders"
              },
              {
                "id": 142761401,
                "url": "https://finnhub.io/api/news?id=b26edc221d172062abcc52a8aa13f2d4c705d37d06c3cd17eda88cad349972be",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Baird  analyst Michael Ha   upgrades Humana (NYSE:HUM) from Neutral to Outperform and raises the price target from $390 to $596.",
                "category": "company",
                "datetime": 1791523165,
                "headline": "Baird Upgrades Humana to Outperform, Raises Price Target to $596"
              },
              {
                "id": 142761247,
                "url": "https://finnhub.io/api/news?id=aba370274d7078cb51e31849577996130a06b21cb5520bf5a1c2579ad8d06a25",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/09/The-Real-Villains-No-Longer-Hide.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Veea jumps 34% after regaining Nasdaq compliance; Freight Technologies leads gainers, while Alignment Healthcare plunges 24% among premarket losers.",
                "category": "company",
                "datetime": 1791520328,
                "headline": "Why Veea Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket"
              },
              {
                "id": 142735873,
                "url": "https://finnhub.io/api/news?id=716305727168b61661e4161443d113b0d4d16107d44cd4878f0a67e803ec9859",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s largest Medicare Advantage contract, covering more than 2 million members, rose from 3.5 stars to 4, putting it back above the bonus threshold.",
                "category": "company",
                "datetime": 1791504338,
                "headline": "HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses"
              },
              {
                "id": 142734200,
                "url": "https://finnhub.io/api/news?id=91359177dfccf1e2b3bbae1bcdc4917dc32471cc46cb1ef7551d3fc1badd2671",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Improving Medicare Advantage ratings isn’t easy. Stars are based on 40-some criteria that encompass patient experience surveys and a range of care metrics.",
                "category": "company",
                "datetime": 1791499680,
                "headline": "Humana Stock Surges After Key Medicare Advantage Plan Gets Higher Rating"
              },
              {
                "id": 142734085,
                "url": "https://finnhub.io/api/news?id=0cbf13399a2e1a979d1ec00b2fe2350da4c0d237f0a0df6a549b59a0be67c24b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana soared after a big Medicare Advantage plan won a higher Star Rating, making it eligible for bonus payments in 2027.",
                "category": "company",
                "datetime": 1791498459,
                "headline": "Humana Soars On Medicare Advantage Star Rating"
              },
              {
                "id": 142733284,
                "url": "https://finnhub.io/api/news?id=1dc6bd4533aecbae3a167ff1df54aacdf1ec6f8a67ddcca39974a85176310e54",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investing.com -- Shares of Humana surged 16.5% on Thursday, while rival Alignment Healthcare tumbled over 20%, after newly released Medicare Advantage Star Ratings revealed sharp reversals in ratings for the two insurers.",
                "category": "company",
                "datetime": 1791493965,
                "headline": "Humana soars, Alignment Healthcare sinks on Medicare rating changes"
              },
              {
                "id": 142732767,
                "url": "https://finnhub.io/api/news?id=a8e2b08d61211646a2d92bbcc25db08a9a29b8e32ed0c3781887edf9d4fcf438",
                "image": "https://www.chartmill.com/images/uploads/CM_Aftermarket_Movers_Small_free_e077945a19.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.",
                "category": "company",
                "datetime": 1791493200,
                "headline": "What's going on in today's after hours session"
              },
              {
                "id": 142761300,
                "url": "https://finnhub.io/api/news?id=1c831cfd47e3c326fe85902166498ffbbf399048220024893bdefe5695188533",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Gainers\n\nSCWorx Corp. - Common Stock (NASDAQ:WORX) shares moved upwards by 48.8% to $6.25 during Thursday's after-market session. \nXORTX Therapeutics (NASDAQ:XRTX) stock increased by 22.7% to $2.27. The market value",
                "category": "company",
                "datetime": 1791479153,
                "headline": "12 Health Care Stocks Moving In Thursday's After-Market Session"
              },
              {
                "id": 142761328,
                "url": "https://finnhub.io/api/news?id=29098ce11cff3483148b86b2789c84cb137159693a8e1c850d8db3067b527e99",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "https://www.cms.gov/newsroom/fact-sheets/2027-medicare-advantage-part-d-star-ratings",
                "category": "company",
                "datetime": 1791477785,
                "headline": "CMS Releases 2027 Medicare Advantage And Part D Star Ratings, With 37% Of MA-PD Contracts Earning Four Or More Stars And 71% Of Enrollees In High-Rated Plans"
              },
              {
                "id": 142731050,
                "url": "https://finnhub.io/api/news?id=1681396f781cbf9d1855b39f314f105e20820acc526960f5f938636605c08ecc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH's Q3 earnings are expected to jump 41.1% despite revenue headwinds. Can improving cost management and restructuring drive further stock gains?",
                "category": "company",
                "datetime": 1791472260,
                "headline": "UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock?"
              },
              {
                "id": 142728921,
                "url": "https://finnhub.io/api/news?id=0dd7d1b383dd91d4ef55e272b4d0e25c1c563ddef68dfa481dcf459a3f0016fa",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.",
                "category": "company",
                "datetime": 1791470101,
                "headline": "Which S&P500 stocks are gapping on Thursday?"
              },
              {
                "id": 142722125,
                "url": "https://finnhub.io/api/news?id=e10613a0013d8486ac96886053619672e4fdd218a227d95a286195abdd3e0e26",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.",
                "category": "company",
                "datetime": 1791455049,
                "headline": "1 Cash-Producing Stock with Impressive Fundamentals and 2 We Find Risky"
              },
              {
                "id": 142700523,
                "url": "https://finnhub.io/api/news?id=dc2312e29f5c1784ca2a83e96ef9fdd7c6bdf3b29550a1ace7c5df07048c4453",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Improving Medicare Advantage ratings isn’t easy. Stars are based on 40-some criteria that encompass patient experience surveys and a range of care metrics.",
                "category": "company",
                "datetime": 1791402240,
                "headline": "Humana Faces Medicare ‘Stars’ Rating. The Result Will Test the Stock."
              },
              {
                "id": 142698432,
                "url": "https://finnhub.io/api/news?id=7b41a39e576b9b9bb47a5350123331a168e5e3491f20cb7d241f26d5b1b8f3e7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "On October 4, Suze Orman, the personal finance author and former CNBC host, had a warning for her podcast listeners covered by UnitedHealth Group (NYSE:UNH): “If you have UnitedHealth Group, about 390,000 people are part of plans that are shutting down.” She said Humana (NYSE:HUM) will cut plans covering about 600,000 people. She also said […]",
                "category": "company",
                "datetime": 1791394956,
                "headline": "Suze Orman Warned 390,000 People Their Medicare Plans Are Shutting Down, Then CNBC Called the Same Stock a Turnaround"
              },
              {
                "id": 140420211,
                "url": "https://finnhub.io/api/news?id=c9045c53ac19ad80d94a07c2e8320fa134ac76c18ad5824d79898864952688d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Intel downgraded, Marvell upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1791381613,
                "headline": "Intel downgraded, Marvell upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 142695110,
                "url": "https://finnhub.io/api/news?id=b33aff18fa22f01db94e755f9d61096eaad5f652c70e88c19dcd7b9ffc05de13",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has logged a sharp year to date rise in its share price, and that move now puts extra focus on whether the current valuation lines up with what the business earns. After such a run, the key issue for any holder or potential buyer is how much of those earnings are already reflected in the US$404.27 price tag. With Humana up 52.9% year to date, a lot now hinges on whether its earnings are strong and resilient enough to support that kind of re-rating. New Medicare Advantage coverage...",
                "category": "company",
                "datetime": 1791378491,
                "headline": "Is Humana (HUM) Stock Priced For Its Stronger Earnings Outlook?"
              },
              {
                "id": 142694944,
                "url": "https://finnhub.io/api/news?id=f88b1d392de6d0ac795c602a741e4ff70abec533c22f4581c4bef87ac0b715f5",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/07/Netapp-Sign--Logo-On-Headquarters-Buildi.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Analysts upgraded NetApp, Humana, Corteva, Afya, with price-target changes for four stocks.",
                "category": "company",
                "datetime": 1791362383,
                "headline": "This NetApp Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday"
              },
              {
                "id": 142694602,
                "url": "https://finnhub.io/api/news?id=fa0021416f14c567615a213398376d6f9dc6f3207145ebafca93424aea24d09e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/07/Micron.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Wall Street analysts revised targets: upgrades for NetApp and Humana; downgrades for PJT Partners; mixed target changes for Redwood, Marvell, Yum and S&P",
                "category": "company",
                "datetime": 1791361187,
                "headline": "Micron To Rally Around 187%? Here Are 10 Top Analyst Forecasts For Wednesday"
              },
              {
                "id": 142696749,
                "url": "https://finnhub.io/api/news?id=2e2457dd122fc3bcb3af4b7a60791f7284973a9304823073ea86bd0c3ba9f4f6",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Cantor Fitzgerald  analyst Sarah James   upgrades Humana (NYSE:HUM) from Neutral to Overweight and raises the price target from $300 to $460.",
                "category": "company",
                "datetime": 1791355376,
                "headline": "Cantor Fitzgerald Upgrades Humana to Overweight, Raises Price Target to $460"
              },
              {
                "id": 142666812,
                "url": "https://finnhub.io/api/news?id=c0adbfa82ff4cfa37f123929df94f6f2d6c0188132fd12ed523bd0d84ea51e90",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH heads into Q3 with investors focused on whether medical-cost gains can hold as Medicare Advantage margins improve without deeper member losses.",
                "category": "company",
                "datetime": 1791304020,
                "headline": "UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore"
              },
              {
                "id": 142665593,
                "url": "https://finnhub.io/api/news?id=250795b088b35ed1b82bfdb6b49d9d54ec1117504f6d0546c96de0ab5b934acd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CNC is narrowing its 2027 Medicare Advantage footprint as elevated costs pressure plan economics, with a sharper focus on dual eligibles.",
                "category": "company",
                "datetime": 1791296880,
                "headline": "Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated"
              },
              {
                "id": 142663323,
                "url": "https://finnhub.io/api/news?id=95f1faa95146151c01f31844b05db7dbcb1e88d23ddf167623a47bd8456bfe9f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., October 06, 2026--Humana Inc. (NYSE: HUM) and the University of Louisville today announced the publication of a new economic impact report examining Humana’s contributions across the state. The analysis, authored by University of Louisville applied economist Thomas E. Lambert, PhD, found that Humana’s operations generated nearly $20 billion in economic activity across Kentucky in 2025, supporting jobs, businesses and communities throughout the Commonwealth.",
                "category": "company",
                "datetime": 1791288000,
                "headline": "Humana Generates Nearly $20 Billion in Economic Impact Across Kentucky, New Report Finds"
              },
              {
                "id": 142663322,
                "url": "https://finnhub.io/api/news?id=ca19ff8708afd153bc07ba8276e065ae2b6d6ed442369f084304b272e7b08e4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "SALT LAKE CITY, October 06, 2026--BlueWind Medical, a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a patient-centric solution for urgency urinary incontinence (UUI), today announced that Humana will provide coverage for implantable tibial neuromodulation therapy for the treatment of UUI, including the Revi System, effective October 1, 2026.",
                "category": "company",
                "datetime": 1791288000,
                "headline": "BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients"
              },
              {
                "id": 142636847,
                "url": "https://finnhub.io/api/news?id=e5de032ddfcb0fdbf2c3348f48f71c794a031187f2b158070a007e9417f129df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth is exiting select Medicare Advantage plans for 2027 as rising medical costs pressure profitability, reshaping its membership mix.",
                "category": "company",
                "datetime": 1791211680,
                "headline": "UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure"
              },
              {
                "id": 142631811,
                "url": "https://finnhub.io/api/news?id=da55aad324fd9ceffd24274ae959ad1cf69a0032fb3ad954e18ac8e696f3d24f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.",
                "category": "company",
                "datetime": 1791192180,
                "headline": "1 Large-Cap Stock on Our Buy List and 2 Facing Challenges"
              },
              {
                "id": 142615678,
                "url": "https://finnhub.io/api/news?id=7ef08fe76ddf72e9df18b9ea1c012b45000fec56025cac6973ff9ffef0bc70d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Insurers are adapting to shifting market conditions with aggressive cost-cutting measures.",
                "category": "company",
                "datetime": 1791043380,
                "headline": "The Insurance Industry Is Shedding Jobs. It’s Not All About AI."
              },
              {
                "id": 142591887,
                "url": "https://finnhub.io/api/news?id=95659ce457d3c5238beca1a4664dd95f6733e39c74c397a8f6dd45402365a0aa",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health's Aetna and Centene are also shrinking their Medicare Advantage offerings as insurers pull back from less profitable markets",
                "category": "company",
                "datetime": 1790961961,
                "headline": "UnitedHealth and Humana cutting Medicare Advantage plans in 2027"
              },
              {
                "id": 142590823,
                "url": "https://finnhub.io/api/news?id=9115cffdd0f5bac173da39794cc5c9f299323af696eb8ae7bfd68296ddb6f1a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Key Stats for UnitedHealth StockCurrent Price: $365. 20Target Price (Mid): ~$586Street Target: ~$482Potential Total Return: ~61%Annualized IRR: ~12% / yearWhat Happened?UnitedHealth Group (UNH:NYSE) is shutting Medicare Advantage plans that cover about 390,000 people for 2027, a company spokesperson told Bloomberg on October 1.",
                "category": "company",
                "datetime": 1790954035,
                "headline": "UnitedHealth Trades at $365 as It Shuts Plans for 390,000 Medicare Advantage Members. Here’s What It Signals for 2027"
              },
              {
                "id": 142581267,
                "url": "https://finnhub.io/api/news?id=8c783d54f798f8baba878d1a33d3bd74c4603a700c35efe48cef11b208f1c6a7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health (CVS) stock lost 12.7% in the past month without company news, and peers UnitedHealth, Cigna and Elevance Health fell too. The S&P 500 rose 0.6% over the same month. The shares now trade 22.5% below their 52-week high. How much further could CVS stock fall if the market itself turns down.",
                "category": "company",
                "datetime": 1790929464,
                "headline": "How Much Downside Is Left In CVS Health Stock?"
              },
              {
                "id": 142562076,
                "url": "https://finnhub.io/api/news?id=d67a2ead5d6046b322da961befefd5bb1027a86893a9f3f29bb38753b5252215",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana already told investors in July how many members it plans to drop. What your neighbor with a surviving plan has not figured out yet is how quietly the costs on that plan changed before open enrollment closes Dec. 7.",
                "category": "company",
                "datetime": 1790879458,
                "headline": "Humana Reports Third-Quarter Earnings Nov. 6, in the Middle of Open Enrollment. Members Got Their Plan-Change Letters Weeks Earlier. Wall Street Got the Numbers in July"
              },
              {
                "id": 142556734,
                "url": "https://finnhub.io/api/news?id=3937a61f4210b68e9dade13ac2178b91cfc79da0cca8618c1cc9b88bdc7156e8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., October 01, 2026--As Medicare’s Annual Election Period (AEP) begins Oct. 15, Humana is offering 2027 Medicare Advantage plans designed to deliver high-value coverage with affordable monthly premiums. Members will have continued access to the benefits they value most – including $0 cost-sharing on in-network primary care visits and labs plus dental, vision, and hearing coverage. Additional 2027 highlights include:",
                "category": "company",
                "datetime": 1790852400,
                "headline": "Humana Maintains Affordable Medicare Advantage Plans and Expands Specialized Care Options for 2027"
              },
              {
                "id": 142558566,
                "url": "https://finnhub.io/api/news?id=659f93818e056e16c3aa2ab5ded2d76ebde2f49b88d69d32e28d7d37ad2cab29",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Additional 2027 highlights include:Medicare Advantage plans in approximately 2,600 counties across 45 states and Washington, D.C., representing more than 80% of U.S. counties.Expanded Chronic Condition Special Needs",
                "category": "company",
                "datetime": 1790838482,
                "headline": "Humana To Offer 2027 Medicare Advantage Plans With Continued Access To The Benefits, Including $0 Cost-Sharing On In-Network Primary Care Visits And Labs Plus Dental, Vision, And Hearing From October 15"
              },
              {
                "id": 142500417,
                "url": "https://finnhub.io/api/news?id=235745f2ec56182ee07c85a38d1c9a880f6d5ddce34e70ce68a6175f09891376",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.",
                "category": "company",
                "datetime": 1790706345,
                "headline": "What Are UNH Stock Investors Betting On?"
              },
              {
                "id": 142499520,
                "url": "https://finnhub.io/api/news?id=8f3d7d9cd0e4b07afb5248c2cc765876b17ee11acc5ba1426933083b8e631a0f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "What a time it’s been for Humana. In the past six months alone, the company’s stock price has increased by a massive 136%, reaching $391.06 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1790698562,
                "headline": "3 Reasons HUM Has Explosive Upside Potential"
              },
              {
                "id": 142498204,
                "url": "https://finnhub.io/api/news?id=1fadd9409892b197cf4a6a4a6d2ac7ceb70dc26e036272850d4db43f80d48aa9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding now depends on costs that management has not yet fully tamed.",
                "category": "company",
                "datetime": 1790690898,
                "headline": "UnitedHealth Stock Has Gone Nowhere for Five Years. Its Dividend Has Not"
              },
              {
                "id": 142443091,
                "url": "https://finnhub.io/api/news?id=a58edb79880cef55fb168c4221ed3e1d3bf6519e46e8f6db8ccccabf029534ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) moved sharply higher this week after Barclays shifted its rating on the insurer to Overweight from Equalweight, indicating that the shares could outperform sector peers. At around US$397.93, Humana’s recent 4.63% 1 day share price return and 3.21% 30 day share price return build on a strong year to date share price return of 50.46%. However, the 3 year total shareholder return has declined 15.34%, suggesting the latest upgrade is being read as a fresh shift in sentiment rather...",
                "category": "company",
                "datetime": 1790474934,
                "headline": "Humana (HUM) Jumped, But What Is Drawing Fresh Attention Now?"
              },
              {
                "id": 142432687,
                "url": "https://finnhub.io/api/news?id=f0b8a5e6ce06eb93cf3259e023de36cbb273540a60b805a268172c8af0497c7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Shares of health insurance company Humana (NYSE:HUM) jumped 8% in the afternoon session after Barclays upgraded the stock from Equalweight to Overweight.",
                "category": "company",
                "datetime": 1790390437,
                "headline": "Why Humana (HUM) Stock Is Up Today"
              },
              {
                "id": 142425534,
                "url": "https://finnhub.io/api/news?id=497c05dbdd185b5daee0e5704ea3d188104bc74edbd1c42af5529f74a5fd3b55",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Healthcare stocks rose late Friday afternoon with the NYSE Healthcare Index increasing 0.3% and the",
                "category": "company",
                "datetime": 1790365811,
                "headline": "Sector Update: Healthcare Stocks Higher Late Afternoon"
              },
              {
                "id": 142425310,
                "url": "https://finnhub.io/api/news?id=b26709e0a9895e9dabe9e7d0cd4238a29c761ebd827ec7d7cdc10dcfa2dff969",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1790363101,
                "headline": "Top S&P500 movers in Friday's session"
              },
              {
                "id": 142425635,
                "url": "https://finnhub.io/api/news?id=cc4bdd8652f900fee558578f88668f84196a101998a77f33f53b723da84b8379",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investing.com -- Humana Inc. (NYSE:HUM) shares rose 6% Friday after Barclays upgraded the health insurer to overweight from equal-weight ahead of the upcoming Medicare Star ratings release.",
                "category": "company",
                "datetime": 1790362782,
                "headline": "Humana surges: Barclays bets big on Medicare star ratings rebound"
              },
              {
                "id": 142425122,
                "url": "https://finnhub.io/api/news?id=0d41d472a3c61877a78173ca1812c78e13c4a7ab5ff1180522c81f12f81fe3e9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Barclays just broke its silence on Humana with a conviction call that sent shares surging well past anything the broader health care sector is doing today, raising the question of whether this upgrade signals the start of something bigger or a rally built on a single opinion.",
                "category": "company",
                "datetime": 1790359149,
                "headline": "Humana Jumps 7% on Barclays Upgrade and $515 Target; UnitedHealth Nudges Higher"
              },
              {
                "id": 142424936,
                "url": "https://finnhub.io/api/news?id=de2a50debecd5a9b78bc22b537fe263eaaee9cb722d5f42e9eb2154e7d9c7d13",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Barclays upgraded Humana stock to Overweight from Neutral and raised its price target to $515 from $407.",
                "category": "company",
                "datetime": 1790352540,
                "headline": "Humana Stock Jumps. Why It Could Be a Big Winner in Next Medicare Star Ratings."
              },
              {
                "id": 142437401,
                "url": "https://finnhub.io/api/news?id=ad0db2f0cba0ca406add338bdd82f007e8b4746106bec86a39fae04943436d63",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/25/Copenhagen--Denmark---August-3--2019-3m-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.",
                "category": "company",
                "datetime": 1790347621,
                "headline": "This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday"
              },
              {
                "id": 140701481,
                "url": "https://finnhub.io/api/news?id=01e6e03b84a7b35aac28fb47af397adbda237de6cf33812e0a2da0c0696c1ae4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "IBM upgrade, SpaceX initiation among today's top calls on Wall Street",
                "category": "company",
                "datetime": 1790343814,
                "headline": "IBM upgrade, SpaceX initiation among today's top calls on Wall Street"
              },
              {
                "id": 142421430,
                "url": "https://finnhub.io/api/news?id=eecd41dedad803ee95bc80410630c118848c067cdb6306e7be95cb266425763c",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.",
                "category": "company",
                "datetime": 1790339700,
                "headline": "Wondering what's happening in today's S&P500  pre-market session?"
              },
              {
                "id": 142438361,
                "url": "https://finnhub.io/api/news?id=59db29e229fb50824677effdce5ce61e6e93999fcf821e67c1867cf2b07cf3a2",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Barclays  analyst Andrew Mok   upgrades Humana (NYSE:HUM) from Equal-Weight to Overweight and raises the price target from $407 to $515.",
                "category": "company",
                "datetime": 1790336298,
                "headline": "Barclays Upgrades Humana to Overweight, Raises Price Target to $515"
              },
              {
                "id": 142437666,
                "url": "https://finnhub.io/api/news?id=0ee6b5f40888c3b2506f45b8472989257b4ee9f302493f3db5fb118e6c7ea69a",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/25/Display-Of-Stock-Market-Quotes.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "U.S. stocks rose Friday; Akamai jumped 8.1% on an $11.6B Anthropic cloud deal, while Atlas Energy, Almonty and others posted strong gains.",
                "category": "company",
                "datetime": 1790335052,
                "headline": "Akamai, Atlas Energy Solutions, People And Other Big Stocks Moving Higher On Friday"
              },
              {
                "id": 142384683,
                "url": "https://finnhub.io/api/news?id=c21395e30aacf5f3bd20fbf13e9006f0d6a4e0d20793588da316f5b79e250925",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.",
                "category": "company",
                "datetime": 1790267681,
                "headline": "What Should CVS Stock Investors Be Watching Now?"
              },
              {
                "id": 142365220,
                "url": "https://finnhub.io/api/news?id=dd32755ec590d1799b7d5ec3ad6f92a43dd03c670e0a73958df4dc85ca5cfada",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "By Exec Edge Editorial Staff Health insurance premiums have climbed for years. Deductibles have climbed right along with them. Yet a growing number of American households are choosing neither, opting instead for a decades-old alternative, which is not health insurance, built around monthly contributions and community values. “People are clearly paying high premiums now,” Liberty […] The post Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Pod",
                "category": "company",
                "datetime": 1790197600,
                "headline": "Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Podcast"
              },
              {
                "id": 142363187,
                "url": "https://finnhub.io/api/news?id=b94d47bbce0ea7953955a6a923c93c2c6a1272c92b020e9b95530b838666b05c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.",
                "category": "company",
                "datetime": 1790180809,
                "headline": "Did UnitedHealth Name The Fix Before Its Stock Ran?"
              },
              {
                "id": 142355707,
                "url": "https://finnhub.io/api/news?id=4662ff75c5601db13998990c5ce991658817bef5e0713a0262b52a0544bdaa8b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Toronto, Ontario--(Newsfile Corp. - September 23, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) (OTCQB: TMPTF) (\"TempraMed\" or the \"Company\"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce it has entered into a distribution agreement dated August 25, 2026 (the \"Distribution Agreement\") with CenterWell Pharmacy, Inc. (\"CenterWell\") the pharmacy services brand of Humana Inc, a major U.S. health...",
                "category": "company",
                "datetime": 1790147100,
                "headline": "TempraMed Announces Distribution Agreement with CenterWell Pharmacy(R), the Pharmacy Services Brand of Humana"
              },
              {
                "id": 142342070,
                "url": "https://finnhub.io/api/news?id=34b69edf2a74f0cb424507a082f3bdd474474b0b9314bc154e1fc4d76ca78ba1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.",
                "category": "company",
                "datetime": 1790100599,
                "headline": "Can UNH Stock Keep Growing Earnings While Its Sales Stall?"
              },
              {
                "id": 142315098,
                "url": "https://finnhub.io/api/news?id=8dc65a87533f54ae58d8fefcc45dfb7d67a5bd4c66cf394114b9b5116ce49f36",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.",
                "category": "company",
                "datetime": 1790017501,
                "headline": "Monday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 142259580,
                "url": "https://finnhub.io/api/news?id=89921bae1997322422e9319a30a5dd8a72284387734060c40f8b39cb717d64b1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.",
                "category": "company",
                "datetime": 1789742520,
                "headline": "Can Cigna's AI Push Help Rein In Rising Healthcare Costs?"
              },
              {
                "id": 142253967,
                "url": "https://finnhub.io/api/news?id=cc96e85bcbd3f911ee04bc5faedce46fa69ce08f2304cc6523cc0ba700260543",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health (CVS) keeps a little over a penny of profit from every dollar it takes in. A net margin of 1.2% reads like a verdict on the business. On $415.1 billion of revenue, one point of net margin is worth over $4 billion, and 1.2% is closer to a floor than a peak. Management has been working on it through 2026.",
                "category": "company",
                "datetime": 1789733701,
                "headline": "Should You Buy CVS Stock For The Margin Aetna Is Rebuilding?"
              },
              {
                "id": 142253117,
                "url": "https://finnhub.io/api/news?id=e11028fe46d2f48c6ef48e72b060b54606b0ee35c8994be445e30b364af77ec5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
                "category": "company",
                "datetime": 1789727560,
                "headline": "2 Unpopular Stocks That Should Get More Attention and 1 We Question"
              },
              {
                "id": 142231473,
                "url": "https://finnhub.io/api/news?id=30df880a56c5295e42ccef56f6654b312adc745dad00fe838d58243ab584a373",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.",
                "category": "company",
                "datetime": 1789659000,
                "headline": "Can Centene Sustain Its Turnaround Amid Membership Pressure?"
              },
              {
                "id": 142223782,
                "url": "https://finnhub.io/api/news?id=d822589fb641971cc9ec09849131d713771573965270318e8d0134de30ce5826",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., September 17, 2026--A new research study finds an association between pharmacy care coordination services and improved health outcomes for cancer patients.",
                "category": "company",
                "datetime": 1789646460,
                "headline": "New Humana research finds association between pharmacy care coordination services and improved health outcomes for cancer patients"
              },
              {
                "id": 142213885,
                "url": "https://finnhub.io/api/news?id=4c0c1b40c39b4cd3cde08377f58d6a5a0e9a8ef017f648fcbdfe8c5296450c0c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "When the Federal Reserve lifts rates and signals they may stay elevated for years, the easy-growth playbook breaks. Cash flows today matter more than promises tomorrow, and investors start to care a lot about balance sheet strength, pricing power and dependable dividends. This article walks through three large cap quality defensive stocks that screen well under those rules and explains how the latest Fed move could affect each one. The three stocks below are a sample of what this quality...",
                "category": "company",
                "datetime": 1789629223,
                "headline": "3 Health Care Stocks Built For Higher Rates"
              },
              {
                "id": 142231472,
                "url": "https://finnhub.io/api/news?id=4dc012de61c556e431b75d6fea82414e40a3feefd245b616e30e4e566497774f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Americans on Medicare Advantage plans may soon get a breakup letter in the mail: Your insurer is canceling your plan.  Humana  and other Advantage insurers are sending letters this fall to plan members about 2027 coverage.  As insurers look to cut costs, some are discontinuing their Advantage plans.",
                "category": "company",
                "datetime": 1789624800,
                "headline": "Losing Your Medicare Plan? There’s a Silver Lining."
              },
              {
                "id": 142198233,
                "url": "https://finnhub.io/api/news?id=62893c934108390cb4e84f708579862ec5e7b3b4291db08db0f2465e4946203f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.",
                "category": "company",
                "datetime": 1789579013,
                "headline": "The One Cost Line UnitedHealth Stock Has Not Caught Up To Yet"
              },
              {
                "id": 142195393,
                "url": "https://finnhub.io/api/news?id=3b6bdf092a40c927edad0623e8edc6e5b71ea42aeeb8a305c4b1d7ce904318a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., September 16, 2026--Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company’s annual nationwide day of service. In its third year, Humana Community Day mobilized more than 18,000 employees across 28 states and Puerto Rico, supported 1,200 nonprofit organizations, and positively impacted 2.25 million lives and community members through volunteer projects focused on food security, neighborhood revitalization, environmental stewardship and soci",
                "category": "company",
                "datetime": 1789560000,
                "headline": "Humana Community Day 2026 Generates 2.2 Million Meals and Community Investments Nationwide"
              },
              {
                "id": 142160447,
                "url": "https://finnhub.io/api/news?id=4b9006c710441c6abe75ec2c80a73863bb98fbc34d77513d5450c84b1e5fbe3b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DUBLIN, Ohio, September 15, 2026--Quantum Health, the industry-leading healthcare navigation company, today announced the appointment of Susan Mani, M.D., as Chief Medical Officer. Dr. Mani will shape Quantum Health's clinical strategy, working to improve healthcare experiences, results and affordability for members and clients.",
                "category": "company",
                "datetime": 1789475400,
                "headline": "Quantum Health Names Dr. Susan Mani as Chief Medical Officer"
              },
              {
                "id": 142160446,
                "url": "https://finnhub.io/api/news?id=d67ac2dbf48f6d0dd329d1ab5d26bad186d15e36a2775d4b1c565d6f5111cfbb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "NEW YORK, September 15, 2026--CalmiGo, developer of the first and only mental health platform that provides immediate relief and long-term care to users suffering from anxiety, PTSD, and panic attacks, announces today that its platform has been selected for CMS’s ACCESS program, offering technology-supported chronic care for behavioral health conditions. Medicare serves over 70 million patients and created the ACCESS program to expand access to technology-supported chronic care. Fourteen additio",
                "category": "company",
                "datetime": 1789470000,
                "headline": "CalmiGo Selected for CMS’s ACCESS Program to Provide Technology-Supported Chronic Care for Behavioral Health Conditions"
              },
              {
                "id": 142158658,
                "url": "https://finnhub.io/api/news?id=808fc4c2ae05c8c77f35414fe4592e4035831fd5e3c07746867bac02ffd8c224",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has staged a sharp rebound in 2024, and with the stock closing at US$407.02, the big question is whether that move still lines up with what the business earns. With the share price up 53.9% year to date, a lot of future expectations are already riding on Humana's earnings power. New research on integrated specialty pharmacy and the push toward lower drug costs may support more stable margins and cash flows, provided Humana can keep members engaged in these models. The analysts...",
                "category": "company",
                "datetime": 1789463559,
                "headline": "Humana (HUM) Stock Could Trade At A Discount Following Its 54% Rebound"
              },
              {
                "id": 142148504,
                "url": "https://finnhub.io/api/news?id=109a37c3b4773b9929db5c05c3b3c1772031edcc000e87fd9e98d6856be6a6c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana listed Counterpart Health among the vendors for its provider-performance and quality programs.",
                "category": "company",
                "datetime": 1789438099,
                "headline": "CLOV Stock Hits Over 2-Month High As Humana Deal Buzz Builds Ahead Of Investor Conferences"
              },
              {
                "id": 142141425,
                "url": "https://finnhub.io/api/news?id=1319d644a68d1a16e7a0fdb153103e0f98cb9c4ea9eee6a94f946c434dcaf49d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.",
                "category": "company",
                "datetime": 1789420257,
                "headline": "CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?"
              },
              {
                "id": 142141467,
                "url": "https://finnhub.io/api/news?id=40c7ec190f17456e6d4cedac5eaa7a53021f0b8cfbc64b185ac0b994c06ac9e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) has spent the past year repairing margins rather than chasing growth. The shares rebounded well ahead of any actual margin recovery: up about 38% over the past six months, though down about 6% over the past three, and still behind the S&P 500 over the past twelve months, 12.2% for the stock against 18.6% for the index. What argues for owning them now shows up in cash running ahead of reported profit.",
                "category": "company",
                "datetime": 1789414884,
                "headline": "Should You Buy UNH Stock Because Its Cash Runs Ahead Of Its Profit?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 154,
            "discarded_article_count": 139
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22.2,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；升放量(近10日4日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 1323570,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1956730,
              "avg_vol_20": 1544680,
              "avg_vol_30": 1323570,
              "range_pct_10": 0.19182646653028218,
              "range_pct_20": 0.207835767638803,
              "range_pct_30": 0.207835767638803,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 4,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.478372885453735,
              "dist_to_20d_high": 0.07912376779846661,
              "down_shrink_days": 2,
              "breakout_level_20d": 456.5,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.9229713860592883
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 1,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 0.9,
            "details": {
              "atrPct": 5.075598268233503,
              "turnoverUsdM": 794.59260726,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.3
            }
          },
          "rrPoints": 1.8,
          "stopLevels": {
            "symbol": "US.HUM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 377.7064,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 1,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.7,
            "stop_loss_percent": 10.2,
            "take_profit_price": 492.3561,
            "target_multiplier": 2.2,
            "technical_strength": 2.3,
            "take_profit_percent": 17.1
          },
          "positionPoints": 0.9,
          "stopLossPoints": 0.6,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.6845304825465863,
          "stopLossPercent": 10.151196536467006,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 21.3368,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 2,
      "atr_pct": 5.08
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 145.09
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1984
    },
    "kdj": {
      "d": 56.24,
      "j": 65.04,
      "k": 59.17,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 47.75
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 3496123,
      "recentSlope": 366982.3,
      "previousSlope": -201040
    },
    "rsi": 65.98,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 383.4718,
      "position": "SAR喺價下",
      "distancePct": 8.78,
      "previousTrend": "上升"
    },
    "ma50": 390.328,
    "macd": {
      "macd": 7.546972946204789,
      "trend": "強烈看漲",
      "signal": 3.091768443913539,
      "histogram": 4.4552045022912505
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 8,
      "value": 401.7337,
      "position": "連續3日>VWAP",
      "consecutiveAbove": 3
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.18,
      "score": 6,
      "avgVolume": 1596594,
      "currentVolume": 1890177
    },
    "derived": {
      "ma20": 393.145,
      "ma50": 390.328,
      "prevClose": 433.5,
      "avgVolume10": 1956488,
      "avgVolume20": 1596594,
      "changePercent": -3.03,
      "avgVolumeForScore": 1596594
    },
    "ma_cross": {
      "ma20": 393.145,
      "ma50": 390.328,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 391.957,
      "prevMa50": 389.4104,
      "spreadPct": 0.72,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 358.7131,
      "upper": 427.5769,
      "position": "上半部"
    },
    "rsi_short": 60.61,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.18
    }
  }
}

{
  "close": 420.38,
  "volume": 1890177,
  "changePercent": -3.03
}